YU, X.; LIU, J.; QIU, H.; HAO, H.; ZHU, J.; PENG, S. Combined inhibition of ACK1 and AKT shows potential toward targeted therapy against KRAS-mutant non-small-cell lung cancer. Bosnian Journal of Basic Medical Sciences, [S. l.], v. 21, n. 2, p. 198–207, 2021. DOI: 10.17305/bjbms.2020.4746. Disponível em: https://www.bjbms.org/ojs/index.php/bjbms/article/view/4746. Acesso em: 6 dec. 2022.